Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 8Sarcoma 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Neoplasms 4Lymphoma 4Hodgkin Disease 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Rectal Neoplasms 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Adenocarcinoma, Follicular 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pleural Effusion, Malignant 2Neuroendocrine Tumors 2Mesothelioma 2Melanoma 2Lymphoma, B-Cell 2Liver Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2

Interventions

fluoromisonidazole 1Taxes 1Radiation 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Stage III Lung Non-Small Cell Cancer AJCC v7 × Fluorodeoxyglucose F18 × Clear all
NCT01507428 2026-04-21

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
138 enrolled 42 charts

Stage III Lung Non-Small Cell Cancer AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡